Yasheng Zhu
China Pharmaceutical University(CN)Second Military Medical University(CN)Changhai Hospital(CN)Medicina(PL)State Key Laboratory of Natural Medicine
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Prostate Cancer Treatment and Research, Cancer-related molecular mechanisms research, Prostate Cancer Diagnosis and Treatment, RNA Research and Splicing
Most-Cited Works
- → Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance(2017)1,012 cited
- → Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression(2021)511 cited
- → Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation(2017)299 cited
- → Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer(2014)181 cited
- → Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation(2015)152 cited
- → Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly(2019)